New Research

Using a Child’s Own Cord Blood Stem Cells
to Treat Cerebral Palsy

A growing body of published data suggests that a child’s own cord blood stem cells may play an important role in helping the body repair damage to nerve and brain tissue. Research has shown that cord blood stem cells have the ability to migrate to the site of injury in the brain and, in certain cases, have been shown to prevent neurological deterioration and even cause cognitive improvement.

Even more exciting, the first FDA-approved human clinical trial evaluating the use of a child’s own cord blood stem cells in the treatment of cerebral palsy is underway at the Medical College of Georgia. Cord Blood Registry is the only cord blood bank to participate in this trial to ensure consistency and quality of the stem cells used.

Additional FDA-approved clinical trials studying the use of a child’s own cord blood stem cells to treat various forms of brain injury are anticipated.

Read Brain Injury Backgrounder

About Cerebral Palsy

Cerebral palsy, a type of brain injury, is a significant unmet medical need that currently has limited treatment options. It is defined as a chronic condition that affects body movement and muscle coordination — as well as other areas such as vision, learning and speech. According to the Centers for Disease Control and Prevention, approximately two to three children in 1,000 are affected by the condition, which currently has no treatment options. The Newborn Possibilities Program would help advance the research for this unmet medical need, ensuring that children who may benefit from emerging therapies that require their own cord blood stem cells have the opportunity to participate in clinical studies.

Donate Today

Donate to the Newborn Possibilities Fund to help defray costs for families participating in ground-breaking therapeutic research using cord blood stem cells.